Ticker Details
Amneal Pharmaceuticals, Inc.
IPO Date:	January 1, 1900
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.96B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 2.50%
Avg Daily Range (30 D):	$0.21 | 1.65%
Avg Daily Range (90 D):	$0.20 | 1.53%

Institutional Daily Volume
Avg Daily Volume:	.44M
Avg Daily Volume (30 D):	1.17M
Avg Daily Volume (90 D):	1.58M

Trade Size
Avg Trade Size (Sh.):	136
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	79

Institutional Trades
Total Institutional Trades:	2,078
Avg Institutional Trade:	$1.94M
Avg Institutional Trade (30 D):	$2.61M
Avg Institutional Trade (90 D):	$4.72M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.29M
Avg Closing Trade (30 D):	$3.61M
Avg Closing Trade (90 D):	$7.21M
Avg Closing Volume:	239.68K

News

Apr 22, 2026 @ 11:15 AM Why Is Amneal Pharmaceuticals Stock Gaining Today?... Source: Nabaparna Bhattacharya

Apr 14, 2026 @ 12:00 PM Amneal Launches First Two Respiratory Metered-Dose... Source: Not Specified

Feb 13, 2026 @ 4:26 PM Accessible Health Platforms Gain Scale Across $6T ... Source: Prnewswire

Jan 27, 2026 @ 11:02 PM TTM Technologies, Dutch Bros, Advanced Energy Indu... Source: Prnewswire

Dec 5, 2025 @ 1:00 PM Amneal Announces Positive Interim Phase 4 ELEVATE-... Source: Amneal Pharmaceuticals

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.39	$.2	$.11
Diluted EPS	$.38	$.19	$.11
Revenue	$3.05B	$722.52M	$814.32M
Gross Profit	$1.18B	$320.11M	$297.19M
Net Income / Loss	$181.32M	$78M	$49.57M
Operating Income / Loss	$435.52M	$141.77M	$112.03M
Cost of Revenue	$1.87B	$402.41M	$517.13M
Net Cash Flow	$136.01M	$-108.53M	$74.53M
PE Ratio

Splits
Aug 26, 2013	1:25